Evaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy: A cross-sectional study

dc.contributor.authorUstaoğlu, Gülbahar
dc.contributor.authorBulut, Duygu Göller
dc.contributor.authorÜyetürk, Ümmügül
dc.contributor.authorUysal, Özge
dc.date.accessioned2021-06-23T19:55:13Z
dc.date.available2021-06-23T19:55:13Z
dc.date.issued2021
dc.departmentBAİBÜ, Diş Hekimliği Fakültesi, Periodontoloji Ana Bilim Dalıen_US
dc.description.abstractAim: To study the dental and periodontal status of women with breast cancer (BCa) having tamoxifen or aromatase inhibitors (AIs) treatment in comparison with control healthy women. Methods: Fifty-one women on tamoxifen therapy, 52 women on AIs therapy and 52 systemically healthy controls were included in the study. The total number of teeth, the number of teeth indicated for extraction, the number of decayed teeth, and the duration of medication were recorded. Periodontal status was evaluated with gingival index (GI); plaque index (PI); bleeding on probing (BOP); probing depth (PD) and clinical attachment loss (CAL). Results: The lowest number of teeth and decayed teeth was found in AIs users (P < .001 and P = .003 respectively). The highest CAL value was seen in AIs users (P = .042) whereas no significant difference was found between the groups in terms of PI, GI, and PD (P = .102, P = .233, and P = .306, respectively). Lower PI was observed in patients using AIs for less than 2 years (P = .048). Conclusions While tamoxifen did not affect the dental and periodontal condition, AIs medication adversely affected the dental and periodontal condition by more tooth loss and higher CAL.en_US
dc.identifier.doi10.1111/scd.12538
dc.identifier.endpage48en_US
dc.identifier.issn0275-1879
dc.identifier.issn1754-4505
dc.identifier.issue1en_US
dc.identifier.pmid33156573en_US
dc.identifier.scopus2-s2.0-85096774633en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage41en_US
dc.identifier.urihttps://doi.org/10.1111/scd.12538
dc.identifier.urihttps://hdl.handle.net/20.500.12491/10755
dc.identifier.volume41en_US
dc.identifier.wosWOS:000586024100001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorUstaoğlu, Gülbahar
dc.institutionauthorBulut, Duygu Göller
dc.institutionauthorÜyetürk, Ümmügül
dc.institutionauthorUysal, Özge
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofSpecial Care In Dentistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAromatase Inhibitorsen_US
dc.subjectBreast Canceren_US
dc.subjectDental Statusen_US
dc.subjectOral Hygieneen_US
dc.subjectPeriodontal Tissueen_US
dc.subjectTamoxifenen_US
dc.titleEvaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy: A cross-sectional studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
gulbahar-ustaoglu.pdf
Boyut:
143.48 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text